Enex Adds AI, Biopharma Expansion Proposals to November 2 Shareholder Meeting Agenda
Enex issued an Oct. 16, 2026 correction finalizing proposals for its Nov. 2 extraordinary shareholders’ meeting. Proposed charter amendments would expand business activities into pharmaceuticals, artificial intelligence and other sectors to diversify operations. Shareholders will also vote on appointing four internal d